Acute dystonia induced by adding midodrine, a selective alpha 1 agonist, to risperidone in a patient with catatonic schizophrenia.
Takahashi
H
H
D000208:Acute Disease; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004421:Dystonia / Q000139:chemically induced* / Q000523:psychology; D005260:Female; D006801:Humans; D008879:Midodrine / Q000009:adverse effects* / Q000627:therapeutic use; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012560:Schizophrenia, Catatonic / Q000150:complications* / Q000188:drug therapy
D000316:Adrenergic alpha-Agonists; D014150:Antipsychotic Agents; D008879:Midodrine; D018967:Risperidone